Joseph F. John

Title
InstitutionMedical University of South Carolina
DepartmentInfectious Diseases
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Karthika IK, John J. Should High Flow Nasal Cannula Therapy Be the Primary Mode of Respiratory Support in a Pediatric Intensive Care Unit? Questions Remain! Indian Pediatr. 2021 Apr 15; 58(4):396-397. PMID: 33883319.
      Citations:    
    2. John J. The treatment of resistant staphylococcal infections. F1000Res. 2020; 9. PMID: 32148777.
      Citations:    
    3. Prabakar J, John J, Arumugham IM, Kumar RP, Sakthi DS. Comparing the Effectiveness of Probiotic, Green Tea, and Chlorhexidine- and Fluoride-containing Dentifrices on Oral Microbial Flora: A Double-blind, Randomized Clinical Trial. Contemp Clin Dent. 2018 Oct-Dec; 9(4):560-569. PMID: 31772463.
      Citations:    
    4. Schmidt MG, Salgado CD, Freeman KD, John JF, Cantey JR, Sharpe PA, Michels HT. Antimicrobial surfaces to prevent healthcare-associated infections: a systematic review - a different view. J Hosp Infect. 2018 07; 99(3):309-311. PMID: 29448050.
      Citations:    
    5. John JF. EDITORIAL. J S C Med Assoc. 2015 Dec-2016 Jan; 111(4):114. PMID: 27141700.
      Citations:    
    6. John JF. Violence Starting but Not Ending in the Home. J S C Med Assoc. 2015 Sep-Oct; 111(3):79. PMID: 27132339.
      Citations:    
    7. John JF. The Forum for South Carolina Physicians. J S C Med Assoc. 2015 Jun; 111(2):44. PMID: 27132329.
      Citations:    
    8. Salgado CD, Sepkowitz KA, John JF, Cantey JR, Attaway HH, Freeman KD, Sharpe PA, Michels HT, Schmidt MG. Reply to Harbarth et al. Infect Control Hosp Epidemiol. 2013 Sep; 34(9):997-9. PMID: 23917920.
      Citations:    
    9. John JF, Steed LL. Antibiotic resistance: a clinical danger beyond 2013. J S C Med Assoc. 2013 Jun; 109(2):54-8. PMID: 24902392.
      Citations:    
    10. Salgado CD, Sepkowitz KA, John JF, Cantey JR, Attaway HH, Freeman KD, Sharpe PA, Michels HT, Schmidt MG. Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit. Infect Control Hosp Epidemiol. 2013 May; 34(5):479-86. PMID: 23571364.
      Citations:    
    11. Ito T, Hiramatsu K, Tomasz A, de Lencastre H, Perreten V, Holden MT, Coleman DC, Goering R, Giffard PM, Skov RL, Zhang K, Westh H, O'Brien F, Tenover FC, Oliveira DC, Boyle-Vavra S, Laurent F, Kearns AM, Kreiswirth B, Ko KS, Grundmann H, Sollid JE, John JF, Daum R, Soderquist B, Buist G. Guidelines for reporting novel mecA gene homologues. Antimicrob Agents Chemother. 2012 Oct; 56(10):4997-9. PMID: 22869575.
      Citations:    
    12. Schmidt MG, Attaway HH, Sharpe PA, John J, Sepkowitz KA, Morgan A, Fairey SE, Singh S, Steed LL, Cantey JR, Freeman KD, Michels HT, Salgado CD. Sustained reduction of microbial burden on common hospital surfaces through introduction of copper. J Clin Microbiol. 2012 Jul; 50(7):2217-23. PMID: 22553242.
      Citations:    
    13. John JF, Baker JM, Fraggos M, Adams C, Hutchison F. All hazards planning and response in the Veterans Administration. J S C Med Assoc. 2011 Jun; 107(3):99-100. PMID: 22057713.
      Citations:    
    14. John JF, Lindsay JA. Clones and drones: do variants of Panton-Valentine leukocidin extend the reach of community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis. 2008 Jan 15; 197(2):175-8. PMID: 18177251.
      Citations:    
    15. John JF, Harvin AM. History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents. Ther Clin Risk Manag. 2007 Dec; 3(6):1143-52. PMID: 18516271.
      Citations:    
    16. John JF. Drug evaluation: tefibazumab--a monoclonal antibody against staphylococcal infection. Curr Opin Mol Ther. 2006 Oct; 8(5):455-60. PMID: 17078388.
      Citations:    
    17. Weems JJ, Steinberg JP, Filler S, Baddley JW, Corey GR, Sampathkumar P, Winston L, John JF, Kubin CJ, Talwani R, Moore T, Patti JM, Hetherington S, Texter M, Wenzel E, Kelley VA, Fowler VG. Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2006 Aug; 50(8):2751-5. PMID: 16870768.
      Citations:    
    18. Louie TJ, Peppe J, Watt CK, Johnson D, Mohammed R, Dow G, Weiss K, Simon S, John JF, Garber G, Chasan-Taber S, Davidson DM. Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis. 2006 Aug 15; 43(4):411-20. PMID: 16838228.
      Citations:    
    19. Majeski JA, John JF. Necrotizing soft tissue infections: a guide to early diagnosis and initial therapy. South Med J. 2003 Sep; 96(9):900-5. PMID: 14513988.
      Citations:    
    20. Nahvi MD, Fitzgibbon JE, John JF, Dubin DT. Sequence analysis of dru regions from methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococcal isolates. Microb Drug Resist. 2001; 7(1):1-12. PMID: 11310798.
      Citations:    
    21. John JF, Rice LB. The microbial genetics of antibiotic cycling. Infect Control Hosp Epidemiol. 2000 Jan; 21(1 Suppl):S22-31. PMID: 10654632.
      Citations:    
    22. Roberts RB, Chung M, de Lencastre H, Hargrave J, Tomasz A, Nicolau DP, John JF, Korzeniowski O. Distribution of methicillin-resistant Staphylococcus aureus clones among health care facilities in Connecticut, New Jersey, and Pennsylvania. . Microb Drug Resist. 2000; 6(3):245-51. PMID: 11144425.
      Citations:    
    23. Dubin DT, Fitzgibbon JE, Nahvi MD, John JF. Topoisomerase sequences of coagulase-negative staphylococcal isolates resistant to ciprofloxacin or trovafloxacin. Antimicrob Agents Chemother. 1999 Jul; 43(7):1631-7. PMID: 10390214.
      Citations:    
    24. Fitzgibbon JE, John JF, Delucia JL, Dubin DT. Topoisomerase mutations in trovafloxacin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1998 Aug; 42(8):2122-4. PMID: 9687420.
      Citations:    
    25. Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997 Sep; 25(3):584-99. PMID: 9314444.
      Citations:    
    26. Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol. 1997 Apr; 18(4):275-91. PMID: 9131374.
      Citations:    
    27. John JF, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997 Mar; 24(3):471-85. PMID: 9114203.
      Citations:    
    28. Donta ST, Peduzzi P, Cross AS, Sadoff J, Haakenson C, Cryz SJ, Kauffman C, Bradley S, Gafford G, Elliston D, Beam TR, John JF, Ribner B, Cantey R, Welsh CH, Ellison RT, Young EJ, Hamill RJ, Leaf H, Schein RM, Mulligan M, Johnson C, Abrutyn E, Griffiss JM, Slagle D, et al. Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group. J Infect Dis. 1996 Sep; 174(3):537-43. PMID: 8769611.
      Citations:    
    29. Bratoeva MP, John JF. In vivo R-plasmid transfer in a patient with a mixed infection of shigella dysentery. Epidemiol Infect. 1994 Apr; 112(2):247-52. PMID: 8149999.
      Citations:    
    30. John JF, Grieshop TJ, Atkins LM, Platt CG. Widespread colonization of personnel at a Veterans Affairs medical center by methicillin-resistant, coagulase-negative Staphylococcus. Clin Infect Dis. 1993 Sep; 17(3):380-8. PMID: 8105982.
      Citations:    
    31. Walsh TJ, Standiford HC, Reboli AC, John JF, Mulligan ME, Ribner BS, Montgomerie JZ, Goetz MB, Mayhall CG, Rimland D, et al. Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob Agents Chemother. 1993 Jun; 37(6):1334-42. PMID: 8328783.
      Citations:    
    32. Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, Kauffman CA, Yu VL. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med. 1993 Mar; 94(3):313-28. PMID: 8452155.
      Citations:    
    33. Montgomerie JZ, John JF, Atkins LM, Gilmore DS, Ashley MA. Increased frequency of large R-plasmids in Klebsiella pneumoniae colonizing patients with spinal cord injury. Diagn Microbiol Infect Dis. 1993 Jan; 16(1):25-9. PMID: 8381063.
      Citations:    
    34. Patrick CH, John JF, Levkoff AH, Atkins LM. Relatedness of strains of methicillin-resistant coagulase-negative Staphylococcus colonizing hospital personnel and producing bacteremias in a neonatal intensive care unit. Pediatr Infect Dis J. 1992 Nov; 11(11):935-40. PMID: 1454435.
      Citations:    
    35. John JF, Atkins LT, Maple PA, Bratoeva M. Activities of newer fluoroquinolones against Shigella sonnei. Antimicrob Agents Chemother. 1992 Oct; 36(10):2346-8. PMID: 1444317.
      Citations:    
    36. Bratoeva MP, John JF, Barg NL. Molecular epidemiology of trimethoprim-resistant Shigella boydii serotype 2 strains from Bulgaria. J Clin Microbiol. 1992 Jun; 30(6):1428-31. PMID: 1624559.
      Citations:    
    37. Singh M, John JF. Isomeric DNA ladder formation of a plasmid encoding tobramycin resistance from Escherichia coli. J Antimicrob Chemother. 1991 Nov; 28(5):627-37. PMID: 1685732.
      Citations:    
    38. Bank HL, John JF, Atkins LM, Schmehl MK, Dratch RJ. Bactericidal action of modulated ultraviolet light on six groups of Salmonella. Infect Control Hosp Epidemiol. 1991 Aug; 12(8):486-9. PMID: 1918893.
      Citations:    
    39. John JF, Ribner BS. Antibiotic resistance in long-term care facilities. Infect Control Hosp Epidemiol. 1991 Apr; 12(4):245-50. PMID: 1905739.
      Citations:    
    40. Reboli AC, John JF, Platt CG, Cantey JR. Methicillin-resistant Staphylococcus aureus outbreak at a Veterans' Affairs Medical Center: importance of carriage of the organism by hospital personnel. Infect Control Hosp Epidemiol. 1990 Jun; 11(6):291-6. PMID: 2373851.
      Citations:    
    41. Bratoeva MP, John JF. Dissemination of trimethoprim-resistant clones of Shigella sonnei in Bulgaria. J Infect Dis. 1989 Apr; 159(4):648-53. PMID: 2647861.
      Citations:    
    42. Reboli AC, John JF, Levkoff AH. Epidemic methicillin-gentamicin-resistant Staphylococcus aureus in a neonatal intensive care unit. Am J Dis Child. 1989 Jan; 143(1):34-9. PMID: 2910044.
      Citations:    
    43. John JF. What price success? The continuing saga of the toxic:therapeutic ratio in the use of aminoglycoside antibiotics. J Infect Dis. 1988 Jul; 158(1):1-6. PMID: 3292658.
      Citations:    
    44. John JF, Reboli AC. MRSA colonization. Infect Control. 1987 Nov; 8(11):445-6. PMID: 3429154.
      Citations:    
    45. Del Bene VE, John JF, Twitty JA, Lewis JW. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance. J Infect Dis. 1986 Aug; 154(2):349-52. PMID: 2941491.
      Citations:    
    46. Bryan CS, Ervin FR, John JF, Richards VR. Cost-effective antimicrobial therapy: an approach for physicians and community hospitals. J S C Med Assoc. 1986 Mar; 82(3):121-248. PMID: 3084868.
      Citations:    
    47. Bryan CS, John JF, Pai MS, Austin TL. Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance. Am J Dis Child. 1985 Nov; 139(11):1086-9. PMID: 3904403.
      Citations:    
    48. Newport MT, John JF, Michel YM, Levkoff AH. Endemic Serratia marcescens infection in a neonatal intensive care nursery associated with gastrointestinal colonization. Pediatr Infect Dis. 1985 Mar-Apr; 4(2):160-7. PMID: 3885179.
      Citations:    
    49. John JF, Twitty JA. Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria. Antimicrob Agents Chemother. 1984 Nov; 26(5):781-4. PMID: 6440481.
      Citations:    
    50. John JF, McNeill WF, Price KE, Kresel PA. Evidence for a chromosomal site specifying amikacin resistance in multiresistant Serratia marcescens. Antimicrob Agents Chemother. 1982 Apr; 21(4):587-91. PMID: 7044303.
      Citations:    
    51. Mullaney DT, John JF. Cefotaxime therapy of serious bacterial infection in adults. Antimicrob Agents Chemother. 1982 Mar; 21(3):421-5. PMID: 6285810.
      Citations:    
    52. John JF, McNeill WF. Characteristics of Serratia marcescens containing a plasmid coding for gentamicin resistance in nosocomial infections. J Infect Dis. 1981 Jun; 143(6):810-7. PMID: 7019356.
      Citations:    
    53. Appleby DH, John JF. Use, misuse, and cost of parenteral cephalosporins at a county hospital. South Med J. 1980 Nov; 73(11):1473-5. PMID: 7444511.
      Citations:    
    54. John JF, McNeill WF. Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci: minimal effect of beta-lactamase. Antimicrob Agents Chemother. 1980 Feb; 17(2):179-83. PMID: 6966906.
      Citations:    
    55. John JF, Rubens CE, Farrar WE. Characteristics of gentamicin resistance in nosocomial infections. Am J Med Sci. 1980 Jan-Feb; 279(1):25-30. PMID: 6768292.
      Citations:    
    56. John JF, Gramling PK, O'Dell NM. Species identification of coagulase-negative staphylococci from urinary tract isolates. J Clin Microbiol. 1978 Oct; 8(4):435-7. PMID: 363741.
      Citations:    
    57. John JF. Nosocomial infection rates at a General Army Hospital. Am J Surg. 1977 Sep; 134(3):381-4. PMID: 900340.
      Citations:    
    58. John JF, Cuetter AC. Spinal syphilis: the problem of fluorescent treponemal antibody in the cerebrospinal fluid. South Med J. 1977 Mar; 70(3):309-11. PMID: 322296.
      Citations:    
    59. John JF. Trimethoprim-sulfamethoxzole: a rational antibiotic combination with many potential indications. J S C Med Assoc. 1976 Jul; 72(7):264-5. PMID: 1067463.
      Citations:    
    John's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (267)
    Explore
    _
    Co-Authors (5)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _